Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Munger

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Clinical Pharmacology and Therapeutics|April 1, 1989
Elucidation of the nifedipine-quinidine interactionM A Munger, R C Jarvis, R Nair, et al.
Journal of the American College of Cardiology|April 8, 1999
Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failureE P Havranek, I Thomas, W B Smith, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1990
Hyperventilation-induced reduction in cerebral blood flow: assessment by positron emission tomographyE M Bednarczyk, W F Rutherford, G P Leisure, et al.
Journal of Clinical Pharmacology|January 1, 1992
Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failureM A Munger, M Chance, R Nair, et al.
British Journal of Clinical Pharmacology|September 1, 1990
Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failureR J Kasmer, R E Cutler, M A Munger, et al.
The American Journal of Cardiology|January 15, 1990
Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failureM A Munger, J R Benotti, J A Green, et al.
Clinical Therapeutics|May 13, 1999
Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study InvestigatorsC A Zuschke, I Keys, M A Munger, et al.
The American Journal of Cardiology|April 15, 1989
Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertensionE M Bednarczyk, W B White, M A Munger, et al.
The Annals of Pharmacotherapy|May 11, 2001
New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelinesS A Spinler, D E Hilleman, J W Cheng, et al.
Critical Care Medicine|May 1, 1990
Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertensionM A Munger, W F Rutherford, L Anderson, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Pharmacology and Therapeutics|April 1, 1989
Elucidation of the nifedipine-quinidine interactionM A Munger, R C Jarvis, R Nair, et al.
Journal of the American College of Cardiology|April 8, 1999
Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failureE P Havranek, I Thomas, W B Smith, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1990
Hyperventilation-induced reduction in cerebral blood flow: assessment by positron emission tomographyE M Bednarczyk, W F Rutherford, G P Leisure, et al.
Journal of Clinical Pharmacology|January 1, 1992
Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failureM A Munger, M Chance, R Nair, et al.
British Journal of Clinical Pharmacology|September 1, 1990
Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failureR J Kasmer, R E Cutler, M A Munger, et al.
The American Journal of Cardiology|January 15, 1990
Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failureM A Munger, J R Benotti, J A Green, et al.
Clinical Therapeutics|May 13, 1999
Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study InvestigatorsC A Zuschke, I Keys, M A Munger, et al.
The American Journal of Cardiology|April 15, 1989
Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertensionE M Bednarczyk, W B White, M A Munger, et al.
The Annals of Pharmacotherapy|May 11, 2001
New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelinesS A Spinler, D E Hilleman, J W Cheng, et al.
Critical Care Medicine|May 1, 1990
Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertensionM A Munger, W F Rutherford, L Anderson, et al.
Pageof 5